(2S)-2-amino-N-[[3-(5-bromofuran-2-yl)-1,2,4-oxadiazol-5-yl]methyl]-3-methylbutanamide;hydrochloride
C12H16BrClN4O3 — CID 120842220
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-2-amino-N-[[3-(5-bromofuran-2-yl)-1,2,4-oxadiazol-5-yl]methyl]-3-methylbutanamide;hydrochloride
(2S)-2-amino-N-[[3-(5-bromofuran-2-yl)-1,2,4-oxadiazol-5-yl]methyl]-3-methylbutanamide;hydrochloride (PubChem CID 120842220) has the molecular formula C12H16BrClN4O3 and a molecular weight of 379.64 g/mol. Its IUPAC name is (2S)-2-amino-N-[[3-(5-bromofuran-2-yl)-1,2,4-oxadiazol-5-yl]methyl]-3-methylbutanamide;hydrochloride.
Molecular Properties
| Compound Name | (2S)-2-amino-N-[[3-(5-bromofuran-2-yl)-1,2,4-oxadiazol-5-yl]methyl]-3-methylbutanamide;hydrochloride |
|---|---|
| PubChem CID | 120842220 |
| Molecular Formula | C12H16BrClN4O3 |
| Molecular Weight | 379.64 g/mol |
| Exact Mass | 378.01 |
| IUPAC Name | (2S)-2-amino-N-[[3-(5-bromofuran-2-yl)-1,2,4-oxadiazol-5-yl]methyl]-3-methylbutanamide;hydrochloride |
| SMILES | CC(C)[C@H](N)C(=O)NCc1nc(-c2ccc(Br)o2)no1.Cl |
| InChI | InChI=1S/C12H15BrN4O3.ClH/c1-6(2)10(14)12(18)15-5-9-16-11(17-20-9)7-3-4-8(13)19-7;/h3-4,6,10H,5,14H2,1-2H3,(H,15,18);1H/t10-;/m0./s1 |
| InChIKey | DKPNWDMWLIEDJP-PPHPATTJSA-N |
| XLogP | 2.11 |
| TPSA | 107.18 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 379.64 |
| LogP ≤ 5 | 2.11 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 120842220 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.